GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
2.060
+0.030 (1.48%)
At close: Jul 18, 2025, 4:00 PM
2.070
+0.010 (0.49%)
After-hours: Jul 18, 2025, 4:07 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $6.48 million as of July 18, 2025. Its market cap has increased by 4.41% in one year.
Market Cap
6.48M
Enterprise Value
4.09M
1-Year Change
4.41%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $6.48M, a decrease of -99.31%. That is a compound annual growth rate of -11.22%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.83B |
| Johnson & Johnson | 373.35B |
| AbbVie | 329.24B |
| Novo Nordisk | 299.09B |
| UnitedHealth Group | 264.62B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 228.77B |
| AstraZeneca | 217.99B |